Observation on clinical efficacy of Qingxuetang combined with allopurinol treating renal hyperuricemia

作者
Jiao Jia
出处
期刊:Journal of Tianjin University of Traditional Chinese Medicine
摘要

[Objective] Curative effect of Qingxuetang combined with different dose of allopurinol in treating renal hyperuricemia. Try to reduce the dose of allopurinol on the basis of traditional Chinese medicine for reducing allopurinol's adverse reactions. [Methods] Ninty patients were randomly divided into three groups, with 30 cases in each group. On basis of routine treatment and Qingxuetang treatment, each group was separately given 150 mg allopurinol, 100 mg allopurinol, 50 mg allopurinol. We observe the chang of Scr、BUN、GFR、UA and symptom score at 0、2、4、8 week. [Results] The total curative effect of three groups were no statistically significant difference(P0.05). Scr, BUN, GFR and symptom score in each group was no statistically significant difference(P 0.05). In reducing UA aspect, Qingxuetang combined with allopurinol 100 mg was no statistically significant difference as allopurinol 150 mg(P 0.05). Qingxuetang combined with allopurinol 50 mg reducing UA was less than with allopurinol 150 mg(P0.05). The cases of Qingxuetang combined with allopurinol 100 mg having adverse reactions were less than with allopurinol 150 mg,and degree of adverse reaction was lighter than with allopurinol 150 mg.[Conclusion] The three groups were no statistically significant differences in improvement of renal function and clinical symptoms in renal hyperuricemia. In reducing UA aspect, Qingxuetang combined with allopurinol 100 mg can replace Qingxuetang combined with allopurinol 150 mg. Qingxuetang combined with allopurinol 100 mg was better effective and security than with allopurinol 150 mg.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
CodeCraft的应助被科研通管家采纳,获得10
刚刚
刚刚
南京市民的应助被科研通管家采纳,获得10
刚刚
乐乐的应助被科研通管家采纳,获得30
刚刚
刚刚
bkagyin的应助被科研通管家采纳,获得10
刚刚
情怀的应助被科研通管家采纳,获得10
刚刚
Owen的应助被科研通管家采纳,获得10
1秒前
DW的应助被科研通管家采纳,获得10
1秒前
NexusExplorer的应助被科研通管家采纳,获得10
1秒前
Estella完成签到 ,获得积分10
1秒前
自觉芒果完成签到 ,获得积分10
1秒前
1秒前
vax完成签到 ,获得积分10
1秒前
bkagyin的应助被科研通管家采纳,获得10
1秒前
SciGPT的应助被科研通管家采纳,获得10
1秒前
英姑的应助被科研通管家采纳,获得10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
酷波er的应助被科研通管家采纳,获得10
2秒前
渡人舟的应助被科研通管家采纳,获得10
2秒前
英姑的应助被科研通管家采纳,获得10
2秒前
SciGPT的应助被科研通管家采纳,获得10
2秒前
无花果的应助被科研通管家采纳,获得10
2秒前
爆米花的应助被科研通管家采纳,获得10
2秒前
3秒前
科研通AI2S的应助被科研通管家采纳,获得10
3秒前
充电宝的应助被科研通管家采纳,获得10
3秒前
大个的应助被科研通管家采纳,获得10
3秒前
完美世界的应助被科研通管家采纳,获得10
3秒前
李健的应助被科研通管家采纳,获得10
3秒前
Jasper的应助被科研通管家采纳,获得10
3秒前
汉堡包的应助被科研通管家采纳,获得10
3秒前
铁锤发布了新的文献求助10
5秒前
brianzk1989发布了新的文献求助10
5秒前
zhou发布了新的文献求助10
5秒前
bbd完成签到,获得积分10
6秒前
eason楽发布了新的文献求助10
8秒前
8秒前
molihuakai的应助被carterwwang采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Rosenblum, Global Change Biology 800
自動車の空力技術 800
Biographisches Lexikon der hervorragenden Ärzte der letzten fünfzig Jahre [1880–1930]. Zugleich Fortsetzung des Biographischen Lexikons der hervorragenden Ärzte aller Zeiten und Völker 600
Organizational Behavior 510
Management and the Arts 510
Issues in Task-Based Language Teaching 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7786454
求助须知:如何正确求助?哪些是违规求助? 9325358
关于积分的说明 20404039
捐赠科研通 7375544
什么是DOI,文献DOI怎么找? 3321700
关于科研通互助平台的介绍 2469733
邀请新用户注册赠送积分活动 2338404